Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Johnson and Johnson
Pharmaceuticals
AstraZeneca
GSK
Novartis
Sanofi
Pfizer
Topics

Advertisement

Advertisement

Johnson and Johnson

Share

Top Latest Popular

Sunday

Does IMAAVY’s Approval and Ongoing Talc Verdict Meaningfully Shift the Bull Case for Johnson & Johnson (JNJ)? Simply Wall St 21:28 Sun, 06 Sep

Friday

Johnson & Johnson Reaches Analyst Target Price Nasdaq 12:35 Fri, 04 Sep

Thursday

Johnson & Johnson (JNJ) Could Be 24% Below Fair Value On FDA Approval News Simply Wall St 21:21 Thu, 03 Sep

Advertisement

Advertisement

AbbVie could take BiTE of Tecvayli market share on Phase III MM win Clinical Trials Arena 14:56 Thu, 03 Sep

Wednesday

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit Business Wire (Press Release) 21:29 Wed, 02 Sep

Notable ETF Inflow Detected - IWD, BRK.B, XOM, JNJ Nasdaq 16:23 Wed, 02 Sep

In the last month

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts Zacks 23:49 Tue, 01 Sep

Texas asks Fifth Circuit to force J&J to pay for Tylenol court shuffle Courthouse News 19:40 Tue, 01 Sep

Linklaters Welcomes J&J Litigation VP In New York Law360 18:01 Tue, 01 Sep

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli Simply Wall St 17:20 Tue, 01 Sep

Linklaters lures Johnson & Johnson litigation head in New York The Lawyer 12:01 Tue, 01 Sep

Linklaters Nabs J&J’s Mass Tort Legal Strategist VP Erik Haas Bloomberg Law 11:00 Tue, 01 Sep

Defamation Litigation Roundup: NYT, J&J, Azerbaijan Law360 03:45 Tue, 01 Sep

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results Business Wire (Press Release) 22:14 Mon, 31 Aug

On the Move: J&J's Hartgrove Drives to Stellantis O'Dwyer's PR Daily 21:02 Mon, 31 Aug

Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. The Motley Fool 10:11 Mon, 31 Aug

Advertisement

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 18:41 Sat, 29 Aug

Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector? Barchart 18:18 Sat, 29 Aug

Forget Nvidia. Johnson & Johnson and 2 Other AI Stocks Are Beating the Market by 29 Points. Barchart 00:10 Sat, 29 Aug

THE FAX SPEAK FOR THEMSELVES: Third Circuit Revives TCPA Class Action Against J&J and Holds a “Patient Support” Fax Can Absolutely... JD Supra 20:09 Fri, 28 Aug

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? Zacks 17:45 Fri, 28 Aug

Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets. The Motley Fool 15:13 Fri, 28 Aug

China approves J&J psoriasis pill Icotyde, says drugmaker Times LIVE 14:49 Thu, 27 Aug

The Zacks Analyst Blog Highlights JPMorgan, Johnson & Johnson, Mastercard and Comstock Zacks 11:01 Thu, 27 Aug

Johnson & Johnson Just Got a Big FDA Win The Motley Fool 06:49 Thu, 27 Aug

Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard Zacks 00:26 Thu, 27 Aug

Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks 23:45 Wed, 26 Aug

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now The Motley Fool 20:39 Wed, 26 Aug

SimuTech Group Engineers Co-Author Chapter in Open-Access Medical Device Vvuq Handbook PR Newswire (Press Release) 15:51 Wed, 26 Aug

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment Simply Wall St 05:22 Wed, 26 Aug

J&J’s Imaavy secures expanded US approval in rare blood disorder Pharmaceutical Technology 21:31 Tue, 25 Aug

Notable ETF Inflow Detected - USMC, V, JNJ, BRK.B Nasdaq 16:13 Tue, 25 Aug

Expanded US Imaavy approval first ever for wAIHA pharmaphorum 14:32 Tue, 25 Aug

Johnson & Johnson scores 1st FDA label expansion for Imaavy FiercePharma 14:23 Tue, 25 Aug

U.S. FDA expands approval for J&J’s drug for rare blood disorder BNN Bloomberg 13:27 Tue, 25 Aug

FDA approves Imaavy® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients PR Newswire (Press Release) 00:13 Tue, 25 Aug

Johnson & Johnson Announces New Global Classification System for Surgical Outcomes WebWire 18:47 Mon, 24 Aug

Louisiana Jury Issues $10 Million Verdict in Talc-Related Mesothelioma Case Against Johnson & Johnson Business Wire (Press Release) 17:25 Mon, 24 Aug

Johnson & Johnson’s multiple myeloma treatment secures EC approval Pharmaceutical Technology 10:06 Mon, 24 Aug

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? The Motley Fool 21:18 Sun, 23 Aug

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis